Home › Coronary Artery Disease › Texas › The Woodlands
Coronary Artery Disease clinical trials in The Woodlands, TX
3 studies for Coronary Artery Disease are looking for participants at sites in and around The Woodlands (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Northwest Houston Heart Center, Tomball · 9 mi away
- Viva Heart and Vein, Tomball · 9 mi away
- Texas Cardiology Associates of Houston, Kingwood · 20 mi away
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- DM Clinical Research - Dallas, Tomball · 9 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Renal Research of Montgomery County, The Woodlands
- DaVita Clinical Research North Houston, Shenandoah · 3 mi away
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY21 studies
- Boston, MA16 studies
- Dallas, TX15 studies
- Atlanta, GA15 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Cleveland, OH13 studies
- Nashville, TN11 studies
- Columbus, OH10 studies
- Durham, NC9 studies
- Los Angeles, CA8 studies
- Memphis, TN8 studies
Other studies in The Woodlands
- Non-Small Cell Lung Cancer15 studies
- Obesity12 studies
- Overweight10 studies
- Breast Cancer10 studies
- Macular Degeneration9 studies
- Cardiovascular Disease9 studies
- Metastatic Cancer9 studies
- Type 2 Diabetes7 studies
- Heart Failure7 studies
- Lung Cancer7 studies
- Atherosclerosis6 studies
- Geographic Atrophy6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.